Go to virtual 3D site

bit.bio

bit.bio
Where: 04
bit.bio is an award-winning human synthetic biology enterprise. bit.bio's mission is to code cells to for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell.

This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.

A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy.

Tel: 01223 787 297
Address: The Dorothy Hodgkin Building
Babraham Research Campus
Cambridge
Website: https://bit.bio/
Email: info@bit.bio

Staff Attending

Ms Abbey Crawford
Commercial Marketing Manager
Bit Bio Limited
Dr Tonya Frolov
Product Manager
bit.bio
Miss Roisin Nicoll
Sales Manager
Bit Bio
Dr Farah Patell-Socha
VP Research Products
bit.bio Ltd

Find out more...

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure Our partners and distributors

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

Brochure ioGlutamatergic Neurons – Human induced neurons for research and HTS – Flyer

Brochure ioGlutamatergic Neurons – Poster by Charles River, validating the neurons for HTS

Brochure ioGlutamatergic Neurons – Additional resources

Brochure ioSkeletal Myocytes – Human induced skeletal muscle cells for research and HTS – Poster by bit.bio

Brochure ioSkeletal Myocytes – Additional resources

Brochure Original paper describing opti-ox reprogramming – Pawlowski et al., Stem Cell Reports, 2017

Brochure 'Reprogramming the stem cell for a new generation of cures' – Drug Discovery World, Spring 2020

Brochure Charles River Announces Strategic Partnership with bit.bio

Brochure bit.bio Secures Distribution Agreement with Abcam

Brochure bit.bio secures $41.5 million of funding from top life sciences investors

LinkedIn URL

Twitter

Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020